1. Curcumin analog GO-Y030 inhibits tumor metastasis and glycolysis
   Takashi MaruYama et al, 2023, The Journal of Biochemistry CrossRef
2. Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response
   Ervin Ç. Mingomataj et al, 2016, Clinical Reviews in Allergy & Immunology CrossRef
3. Grating coupled SPR microarray analysis of proteins and cells in blood from mice with breast cancer
   A. Mendoza et al, 2016, The Analyst CrossRef
4. FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma
   Eva Skarmoutsou et al, 2018, International Journal of Molecular Medicine CrossRef
5. Therapeutic blockade of Foxp3 in experimental breast cancer models
   Mariela A. Moreno Ayala et al, 2017, Breast Cancer Research and Treatment CrossRef
6. FoxP3 and IDO in Canine Melanocytic Tumors
   Ilaria Porcellato et al, 2019, Veterinary Pathology CrossRef
7. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies
   Rodolfo Daniel Cervantes-Villagrana et al, 2020, Signal Transduction and Targeted Therapy CrossRef
8. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma
   T. Komel et al, 2021, Bioelectrochemistry CrossRef
9. Lessons from transmissible cancers for immunotherapy and transplant
   Rafael Cardoso Maciel Costa Silva et al, 2022, Immunological Medicine CrossRef
10. Foxp3 expression in T regulatory cells and other cell lineages
    Christel Devaud et al, 2014, Cancer Immunology, Immunotherapy CrossRef
11. Effects of CpG Oligodeoxynucleotide 1826 on transforming growth factor-beta 1 and radiation-induced pulmonary fibrosis in mice
    Xuan Li et al, 2016, Journal of Inflammation CrossRef
12. Immunostimulators and Immunomodulators in Cancer Treatment
    Brianna Oliver et al, 2015, Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies CrossRef